Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Estradiol 3-phosphate controlled-release - Redwood Pharma

Drug Profile

Estradiol 3-phosphate controlled-release - Redwood Pharma

Alternative Names: 17beta-Estradiol-3-phosphate; Estradiol, 3-(dihydrogen phosphate); Estradiol-3-phosphate; RP101 - Redwood Pharma

Latest Information Update: 25 Jul 2022

Price :
$50 *
Note:
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Redwood Pharma
  • Class Estradiol congeners; Eye disorder therapies; Hormonal replacements; Small molecules
  • Mechanism of Action Estrogen receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes - Dry eyes

Highest Development Phases

  • Phase II Dry eyes

Most Recent Events

  • 25 Jul 2022 No development reported - Phase-II for Dry eyes (In children, In the elderly, In adults) in Hungary, Germany, Austria (Ophthalmic)
  • 22 Mar 2021 Safety and efficacy data from phase II trial in Dry eye disease released by Redwood Pharma
  • 28 Dec 2020 Efficacy data from a phase II trial in Dry eyes released by Redwood Pharma

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top